Hepatopancreatoduodenectomy for the treatment of extrahepatic cholangiocarcinoma.
作者信息
Porcu Alberto, Deiana Giulia, Feo Claudio F, Ninniri Chiara, Turilli Davide, Tanda Lorena, Fancellu Alessandro
机构信息
Department of Clinical, Surgical and Experimental Sciences, Unit of General Surgery 2 - Clinica Chirurgica, University of Sassari, Sassari, Italy.
Unit of Radiological Sciences, AOU Sassari, Sassari, Italy.
出版信息
Hepatobiliary Pancreat Dis Int. 2023 Aug;22(4):430-433. doi: 10.1016/j.hbpd.2022.08.011. Epub 2022 Aug 21.
PMID:36041972
Abstract
摘要
相似文献
1
Hepatopancreatoduodenectomy for the treatment of extrahepatic cholangiocarcinoma.肝胰十二指肠切除术治疗肝外胆管癌
Hepatobiliary Pancreat Dis Int. 2023 Aug;22(4):430-433. doi: 10.1016/j.hbpd.2022.08.011. Epub 2022 Aug 21.
2
Extrahepatic cholangiocarcinoma: current surgical strategy.肝外胆管癌：当前的手术策略
Surg Oncol Clin N Am. 2009 Apr;18(2):269-88, viii. doi: 10.1016/j.soc.2008.12.003.
3
Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.采用经十二指肠途径行左半肝切除术、尾状叶切除术及肝外胆管完全切除术治疗源于胆管乳头状瘤病的肝门部胆管癌。
J Surg Oncol. 2008 Aug 1;98(2):139-42. doi: 10.1002/jso.21089.
4
Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.肿块形成型肝内胆管癌表现为肝外胆管肿瘤生长及浅表扩散。
Hepatogastroenterology. 2003 Jan-Feb;50(49):21-3.
5
Surgery of extrahepatic bile duct cancer - current evidence and recommendations.肝外胆管癌的外科治疗——当前证据与建议。
Rozhl Chir. 2022 Fall;101(9):416-420. doi: 10.33699/PIS.2022.101.9.416-420.
6
The current management of hilar cholangiocarcinoma.肝门部胆管癌的当前治疗方法
Adv Surg. 1999;33:345-73.
7
ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.ASO作者反思：全身免疫炎症指数在肝外胆管癌切除术后是否是一个有用的生物标志物：来自美国肝外胆管恶性肿瘤联盟的结果。
Ann Surg Oncol. 2022 Nov;29(12):7615-7616. doi: 10.1245/s10434-022-12105-y. Epub 2022 Jul 1.
8
CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.CD10+ 纤维母细胞在肝门部/肝外胆管癌的进展中比在周围型肝内胆管癌中更为活跃。
Histopathology. 2009 Oct;55(4):423-31. doi: 10.1111/j.1365-2559.2009.03398.x.
9
Cholangiocarcinoma.胆管癌
Surg Pathol Clin. 2018 Jun;11(2):403-429. doi: 10.1016/j.path.2018.02.005.
10
[Extrahepatic cholangiocarcinoma: current state of palliation therapy].[肝外胆管癌：姑息治疗的现状]
Zentralbl Chir. 2012 Dec;137(6):522-6. doi: 10.1055/s-0031-1283917. Epub 2012 Apr 17.
Zotero 插件